Skip to main content
Fig. 2 | Trials

Fig. 2

From: An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

Fig. 2

ILiAD visit schedule The tasks to be completed by the participant, carer and researcher are listed. Visits can typically be completed within 2 h although the screening and baseline visit can take around 4 h. IMP is provided at each visit also. * = tests will not be repeated if acceptable results are already available from within 3 months of recruitment date. Abbreviations: TC = telephone consultation; BADLS = Bristol Activities of Daily Living Scale; DSRS = Dementia Severity Rating Scale; MoCA = Montreal Cognitive Assessment; NPI = Neuropsychiatry Inventory; QoL = Quality of Life; EQ-5D = Euro-QoL Quality of Life Measure

Back to article page

Trials

ISSN: 1745-6215